--- SEARCH ---
WEATHER
CHINA
INTERNATIONAL
BUSINESS
CULTURE
GOVERNMENT
SCI-TECH
ENVIRONMENT
SPORTS
LIFE
PEOPLE
TRAVEL
WEEKLY REVIEW
Learning Chinese
Learn to Cook Chinese Dishes
Exchange Rates
Hotel Service
China Calendar


Hot Links
China Development Gateway
Chinese Embassies


Unsafe Injections Kill 390,000 Prematurely

About 390,000 Chinese have died prematurely from unsafe injections, said a think tank of China's Ministry of Health Thursday.

The Thinktank Health Research Center released the statistics at a seminar on unsafe injection that opened Thursday in Beijing.

The results show that AIDS and HBV (Hepatitis B Infection) caused by unsafe injections have caused 390,000 premature deaths and 6.89 million Disability Adjustment Life Year losses. The direct medical spending on unsafe injection has reached US$142 million.

There are 3 billion injections in China annually, one fifth of the global total. In poor western regions and rural areas, it's a common practice of grass-roots clinics to reuse disposable syringes without effective disinfection measures.

Statistics show that 30 percent of immune injections and 50 percent of therapeutic ones are unsafe. In western rural areas, more 70 percent of disposable syringes for single use are reused.

Unsafe injections have also caused damage to doctors and nurses. Guo Yanhong, in charge of the MOH injection department, said one million medical workers had been hurt by needles annually, some of whom got HBV or HIV/AIDS.

China has 840,000 HIV carriers and 120 million HBV carriers, 10 percent of the total population. Two thirds of the latter caught the virus before the age of five.

Ye Lei, national director of the United States Centers for Disease Control and Prevention Global AIDS Program-China, believes that the best way to avoid unsafe injections is to use Auto- disabled (AD) Syringes which can be self-destructed after the injection.

Ye said AD Syringes, with a price only US$0.01 higher than the current single-use ones, are cheap enough for rural consumers.

However, the product is far from popular in the country. Despite 30 manufacturers with an annual capacity of 1.7 billion, the annual sales of AD Syringes linger at 100 million due to low domestic demand.

(China Daily August 6, 2004)

Beijing Expands AIDS Monitoring
Time to Act on HIV/AIDS
AIDS Outbreak Likely in Hebei
China Can Lead New Fight in War on AIDS
Hunan Lifts Ban on HBV Carriers
New Hepatitis B Virus Genes Decoded
Print This Page
|
Email This Page
About Us SiteMap Feedback
Copyright © China Internet Information Center. All Rights Reserved
E-mail: webmaster@china.org.cn Tel: 86-10-68326688